CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 1 filers reported holding CARDIOME PHARMA CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $7,520,000 | +51.8% | 3,241,550 | +1.4% | 4.03% | +35.7% |
| Q4 2017 | $4,953,000 | -18.9% | 3,195,692 | +11.5% | 2.97% | -17.5% |
| Q3 2017 | $6,106,000 | -15.3% | 2,866,785 | +79.7% | 3.60% | -7.6% |
| Q2 2017 | $7,212,000 | -13.1% | 1,595,549 | -42.1% | 3.89% | -16.7% |
| Q1 2017 | $8,299,000 | -4.8% | 2,757,260 | -12.7% | 4.68% | -9.9% |
| Q4 2016 | $8,718,000 | +45.2% | 3,158,816 | +64.6% | 5.19% | +6.0% |
| Q3 2016 | $6,006,000 | – | 1,918,722 | – | 4.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,918,722 | $6,006,000 | 4.90% |
| Tamarack Advisers, LP | 4,400,000 | $13,882,000 | 2.18% |
| AlphaOne Investment Services, LLC | 580,965 | $1,824,000 | 0.60% |
| CLOUGH CAPITAL PARTNERS L P | 3,061,064 | $9,581,000 | 0.50% |
| Rock Springs Capital Management LP | 1,200,000 | $3,751,000 | 0.24% |
| TURNER INVESTMENTS LLC | 150,000 | $470,000 | 0.16% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 5,397,007 | $16,893,000 | 0.14% |
| SABBY MANAGEMENT, LLC | 484,505 | $1,521,000 | 0.06% |
| PUTNAM INVESTMENTS LLC | 3,673,622 | $11,536,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 28,900 | $90,000 | 0.01% |